Schedule 13G ownership disclosure

Epizyme, Inc.

Security class unavailable · CUSIP: 29428V104

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,860,843
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-18-000005
Form type
SC 13G
Filer
Epizyme, Inc.
CIK
CIK 1571498
Filed
Feb 14, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub